Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

PS-028: Fibrinogen antagonist from Taisho

May 3, 1996

Fuji Pharm. reports new antiplatelet agent

May 3, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Genelabs develops two oral antithrombotics

April 26, 1996

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Antiplatelet agents emerging from the Thomae pipeline

April 19, 1996

Corvas presents preclinical data for NAPc2

April 19, 1996

First clinical results for CVS-1123

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...